Clincosm LogoSign in Get a demo

acute myeloid leukemia

Showing 1 - 25 of 941
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GilteRInf 2022 Study (Gilteritinib Related Infections)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Roma, RM, Italy
    Maria Ilaria Del Principe
Mar 17, 2023

Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 15, 2023

Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

Not yet recruiting
  • Acute Myeloid Leukemia
  • Genetic Predisposition to Disease
  • Collection of blood sample of bone marrow (cohort 1)
  • Collection of blood sample of bone marrow (cohort 2 and 3)
  • (no location specified)
Mar 6, 2023

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Acute Myeloid Leukemia Trial in United States (ADCLEC.syn1 CAR T cells, Conditioning chemo)

Not yet recruiting
  • Acute Myeloid Leukemia
  • ADCLEC.syn1 CAR T cells
  • Conditioning chemotherapy
  • Basking Ridge, New Jersey
  • +6 more
Mar 1, 2023

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

Recruiting
  • Acute Myeloid Leukemia
  • allogenic NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Rochester, Minnesota
  • +1 more
Feb 15, 2023

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dose Escalation -tagraxofusp-erzs
  • Dose Expansion at RP2D -tagraxofusp-erzs
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 27, 2023

Acute Myeloid Leukemia Trial in Beijing, Tianjin (LCAR-AMDR Cells Product)

Recruiting
  • Acute Myeloid Leukemia
  • LCAR-AMDR Cells Product
  • Beijing, Beijing, China
  • +1 more
Jan 28, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 26, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • (no location specified)
Jan 13, 2023

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
  • Defactinib
  • Sydney, New South Wales, Australia
  • +3 more
Jan 12, 2023

Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Anti-CD33 CAR T-cells
  • Lymphodepletion Therapy
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

Recruiting
  • Acute Myeloid Leukemia
  • CIML-NK Cells
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jan 4, 2023

Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • CAV Regimen
  • MEC Regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Dec 22, 2022

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Lymphoma, Mantle-Cell
  • (no location specified)
Dec 22, 2022

Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
    University of Miami
Dec 22, 2022

Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 13, 2022

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022